4//SEC Filing
Kirk Christopher J. 4
Accession 0001209191-23-054837
CIK 0001645666other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:25 PM ET
Size
5.5 KB
Accession
0001209191-23-054837
Insider Transaction Report
Form 4
Kirk Christopher J.
DirectorCEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-11-08+875,000→ 875,000 totalExercise: $0.84Exp: 2033-11-07→ Common Stock (875,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on December 7, 2023, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001744253
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:25 PM ET
- Size
- 5.5 KB